Metabolic Reprogramming Helps to Define Different Metastatic Tropisms in Colorectal Cancer

Approximately 25% of colorectal cancer (CRC) patients experience systemic metastases, with the most frequent target organs being the liver and lung. Metabolic reprogramming has been recognized as one of the hallmarks of cancer. Here, metabolic and functional differences between two CRC cells with di...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero-Calle, Ana, Gómez de Cedrón, Marta, Quijada-Freire, Adriana, Solís-Fernández, Guillermo, López-Alonso, Victoria, Espinosa-Salinas, Isabel, Peláez-García, Alberto, Fernández-Aceñero, María Jesús, Ramírez de Molina, Ana, Barderas, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358964/
https://www.ncbi.nlm.nih.gov/pubmed/35957902
http://dx.doi.org/10.3389/fonc.2022.903033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358964/
https://www.ncbi.nlm.nih.gov/pubmed/35957902
http://dx.doi.org/10.3389/fonc.2022.903033

Ejemplares similares